These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31176759)

  • 1. Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet.
    de Mendonça M; Dos Santos BAC; de Sousa É; Rodrigues AC
    Mol Cell Endocrinol; 2019 Aug; 493():110480. PubMed ID: 31176759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis.
    Hsiao PJ; Chiou HC; Jiang HJ; Lee MY; Hsieh TJ; Kuo KK
    Sci Rep; 2017 Aug; 7(1):9030. PubMed ID: 28831172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis.
    Marinovic MP; Sousa-Filho CPB; Batista FAH; Avelino TM; Cogliati B; Figueira ACM; Otton R; Rodrigues AC
    J Nutr Biochem; 2022 May; 103():108957. PubMed ID: 35134507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
    J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
    van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
    Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
    PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
    Liu Q; Liu Y; Li F; Gu Z; Liu M; Shao T; Zhang L; Zhou G; Pan C; He L; Cai J; Zhang X; Barve S; McClain CJ; Chen Y; Feng W
    J Nutr Biochem; 2020 Jan; 75():108256. PubMed ID: 31760308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study.
    Deng W; Meng Z; Sun A; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):411-415. PubMed ID: 28946547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation.
    Khaleel EF; Abdel-Aleem GA
    Arch Physiol Biochem; 2019 Feb; 125(1):64-78. PubMed ID: 29429367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD.
    Ma H; You GP; Cui F; Chen LF; Yang XJ; Chen LG; Lu HD; Zhang WQ
    Ann Hepatol; 2015; 14(1):108-17. PubMed ID: 25536648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
    Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
    Gastaldelli A; Sabatini S; Carli F; Gaggini M; Bril F; Belfort-DeAguiar R; Positano V; Barb D; Kadiyala S; Harrison S; Cusi K
    Liver Int; 2021 Nov; 41(11):2659-2670. PubMed ID: 34219361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.